In vivo dynamics of skeletal muscle Dystrophin in zebrafish embryos revealed by improved FRAP analysis

eLife

Volumn 4, Issue OCTOBER2015, 2015, Pages

  Bajanca, Fernanda ^a,b   Gonzalez Perez, Vinicio ^c   Gillespie, Sean J ^c   Beley, Cyriaque ^d,e   Garcia, Luis ^d,e   Theveneau, Eric ^b   Sear, Richard P ^c   Hughes, Simon M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e CENTRE SCIENTIFIQUE DE MONACO   (Monaco)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ANALYSIS OF VARIANCE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DYNAMICS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROSCOPY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; SKELETAL MUSCLE; ZEBRA FISH; ANIMAL; CHEMISTRY; EMBRYOLOGY; GROWTH, DEVELOPMENT AND AGING; HUMAN;

ANIMALS; DYSTROPHIN; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMANS; MUSCLE, SKELETAL; ZEBRAFISH;

EID: 84946600683     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.06541     Document Type: Article

References (69)

1. Akkina R. 2013. New generation humanized mice for virus research: comparative aspects and future prospects. Virology 435:14-28. doi: 10.1016/j.virol.2012.10.007.
2. Arrio-Dupont M, Foucault G, Vacher M, Devaux PF, Cribier S. 2000. Translational diffusion of globular proteins in the cytoplasm of cultured muscle cells. Biophysical Journal 78:901-907. doi: 10.1016/S0006-3495(00)76647-1.
3. Attfield KE, Dendrou CA, Fugger L. 2012. Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis. Immunological Reviews 248:10-22. doi: 10.1111/j. 1600-065X.2012.01132.x.
4. Bajanca F, Gonzalez-Perez V, Gillespie SJ, Beley C, Garcia LM, Theveneau E, Sear RP, Hughes SM. 2015. Data from: In vivo dynamics of muscle Dystrophin revealed by improved FRAP analysis. Dryad Digital Repository. doi: 10.5061/dryad.qg8dt.
5. Bassett DI, Bryson-Richardson RJ, Daggett DF, Gautier P, Keenan DG, Currie PD. 2003. Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo. Development 130:5851-5860. doi: 10.1242/ dev.00799.
6. Berger J, Berger S, Hall TE, Lieschke GJ, Currie PD. 2010. Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscular Disorders 20:826-832. doi: 10.1016/j.nmd.2010.08.004.
7. Berger J, Berger S, Jacoby AS, Wilton SD, Currie PD. 2011. Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish. Journal of Cellular and Molecular Medicine 15:2643-2651. doi: 10.1111/j.1582-4934.2011.01260.x.
8. Bhasin N, Law R, Liao G, Safer D, Ellmer J, Discher BM, Sweeney HL, Discher DE. 2005. Molecular extensibility of minidystrophins and a dystrophin rod construct. Journal ofMolecular Biology 352:795-806. doi: 10.1016/j.jmb.2005.07.064.
9. Böhm S, Jin H, Hughes SM, Roberts RG, Hinits Y. 2008. Dystrobrevin and dystrophin family gene expression in zebrafish. Gene Expression Patterns 8:71-78. doi: 10.1016/j.modgep.2007.10.004.
10. Boverhof DR, Chamberlain MP, Elcombe CR, Gonzalez FJ, Heflich RH, Hernández LG, Jacobs AC, Jacobson-Kram D, Luijten M, Maggi A, Manjanatha MG, Benthem JV, Gollapudi BB. 2011. Transgenic animal models in toxicology: historical perspectives and future outlook. Toxicological Sciences 121:207-233. doi: 10.1093/toxsci/kfr075.
11. Brangwynne CP, Koenderink GH, MacKintosh FC, Weitz DA. 2008. Cytoplasmic diffusion: molecular motors mix it up. The Journal of Cell Biology 183:583-587. doi: 10.1083/jcb.200806149.
12. Brangwynne CP, Koenderink GH, MacKintosh FC, Weitz DA. 2009. Intracellular transport by active diffusion. Trends in Cell Biology 19:423-427. doi: 10.1016/j.tcb.2009.04.004.
13. Castle BT, Howard SA, Odde DJ. 2011. Assessment of transport mechanisms underlying the bicoid morphogen gradient. Cellular and Molecular Bioengineering 4:116-121. doi: 10.1007/s12195-010-0157-4.
14. Chal J, Oginuma M, Al Tanoury Z, Gobert B, Sumara O, Hick A, Bousson F, Zidouni Y, Mursch C, Moncuquet P, Tassy O, Vincent S, Miyanari A, Bera A, Garnier JM, Guevara G, Hestin M, Kennedy L, Hayashi S, Drayton B, Cherrier T, Gayraud-Morel B, Gussoni E, Relaix F, Tajbakhsh S, PourquiéO. 2015. Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy. Nature Biotechnology 33:962-969. doi: 10.1038/nbt.3297.
15. Chambers SP, Dodd A, Overall R, Sirey T, Lam LT, Morris GE, Love DR. 2001. Dystrophin in adult zebrafish muscle. Biochemical and Biophysical Research Communications 286:478-483. doi: 10.1006/bbrc.2001.5424.
16. Chevron MP, Girard F, Claustres M, Demaille J. 1994. Expression and subcellular localization of dystrophin in skeletal, cardiac and smooth muscles during the human development. Neuromuscular Disorders 4:419-432. doi: 10.1016/0960-8966(94)90081-7.
17. Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ, Dickson G, WoodMJ, Wilton SD, Straub V, Kole R, Shrewsbury SB, Sewry C, Morgan JE, Bushby K, Muntoni F. 2011. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378:595-605. doi: 10.1016/S0140-6736(11)60756-3.
18. Clerk A, Strong PN, Sewry CA. 1992. Characterisation of dystrophin during development of human skeletal muscle. Development 114:395-402.
19. Cole NJ, Hall TE, Don EK, Berger S, Boisvert CA, Neyt C, Ericsson R, Joss J, Gurevich DB, Currie PD. 2011. Development and evolution of the muscles of the pelvic fin. PLOS Biology 9:16-18. doi: 10.1371/journal.pbio. 1001168.
20. Coscoy S, Waharte F, Gautreau A, Martin M, Louvard D, Mangeat P, Arpin M, Amblard F. 2002. Molecular analysis of microscopic ezrin dynamics by two-photon FRAP. Proceedings of the National Academy of Sciences of USA 99:12813-12818. doi: 10.1073/pnas.192084599.
21. De Beco S, Perney JB, Coscoy S, Amblard F. 2015. Mechanosensitive adaptation of e-cadherin turnover across adherens junctions. PLOS ONE 10:e0128281. doi: 10.1371/journal.pone.0128281.
22. Delanoë-Ayari H, Al Kurdi R, Vallade M, Gulino-Debrac D, Riveline D. 2004. Membrane and acto-myosin tension promote clustering of adhesion proteins. Proceedings of the National Academy of Sciences of USA 101:2229-2234. doi: 10.1073/pnas.0304297101.
23. Ervasti JM, Campbell KP. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. The Journal of Cell Biology 122:809-823. doi: 10.1083/jcb.122.4.809.
24. Friedel M, Baumketner A, Shea JE. 2006. Effects of surface tethering on protein folding mechanisms. Proceedings of the National Academy of Sciences of USA 103:8396-8401. doi: 10.1073/pnas.0601210103.
25. González-Pérez V, Schmierer B, Hill CS, Sear RP. 2011. Studying Smad2 intranuclear diffusion dynamics by mathematical modelling of FRAP experiments. Integrative Biology 3:197-207. doi: 10.1039/c0ib00098a.
26. Guyon JR, Mosley AN, Zhou Y, O'Brien KF, Sheng X, Chiang K, Davidson AJ, Volinski JM, Zon LI, Kunkel LM. 2003. The dystrophin associated protein complex in zebrafish. HumanMolecular Genetics 12:601-615. doi: 10.1093/hmg/ddg071.
27. Hinits Y, Hughes SM. 2007. Mef2s are required for thick filament formation in nascent muscle fibres. Development 134:2511-2519. doi: 10.1242/dev.007088.
28. Holt CE, Bullock SL. 2009. Subcellular mRNA localization in animal cells and why it matters. Science 326:1212-1216. doi: 10.1126/science.1176488.
29. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702. doi: 10.1038/355696a0.
30. Jin H, Tan S, Hermanowski J, Böhm S, Pacheco S, McCauley JM, Greener MJ, Hinits Y, Hughes SM, Sharpe PT, Roberts RG. 2007. The dystrotelin, dystrophin and dystrobrevin superfamily: new paralogues and old isoforms. BMC Genomics 8:19. doi: 10.1186/1471-2164-8-19.
31. Johnson NM, Farr GH, Maves L. 2013. The HDAC Inhibitor TSA Ameliorates a zebrafish model of duchenne muscular dystrophy. PLOS Currents 5. doi: 10.1371/currents.md.8273cf41db10e2d15dd3ab827cb4b027.
32. Kääriäinen M, Kääriäinen J, Järvinen TLN, Nissinen L, Heino J, Järvinen M, Kalimo H. 2000. Integrin and dystrophin associated adhesion protein complexes during regeneration of shearing-type muscle injury. Neuromuscular Disorders 10:121-132. doi: 10.1016/S0960-8966(99)00077-2.
33. Kameta N, Minamikawa H, Someya Y, Yui H, Masuda M, Shimizu T. 2010. Confinement effect of organic nanotubes toward green fluorescent protein (GFP) depending on the inner diameter size. Chemistry 16:4217-4223. doi: 10. 1002/chem.200903413.
34. Kawahara G, Kunkel LM. 2013. Zebrafish based small molecule screens for novel DMD drugs. Drug Discovery Today Technologies 10:e91-e96. doi: 10.1016/j.ddtec.2012.03.001.
35. Kinsey ST, Locke BR, Dillaman RM. 2011. Molecules in motion : influences of diffusion on metabolic structure and function in skeletal muscle. The Journal of Experimental Biology 215:263-274. doi: 10.1242/jeb.047985.
36. Kloc M, Zearfoss NR, Etkin LD. 2002. Mechanisms of subcellular mRNA localization. Cell 108:533-544. doi: 10. 1016/S0092-8674(02)00651-7.
37. Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettecken T, Meng G, Müller CR, Lindlöf M, Kaariainen H, de la Chapelle A, Kiuru A, Savontaus M-L, Gilgenkrantz H, Récan D, Chelly J, Kaplan J-C, Covone AE, Archidiacono N, Romeo G, Liechti-Gallati S, Schneider V, Braga S, Moser H, Darras BT, Murphy P, Francke U, Chen JD, Morgan G, Denton M, Greenberg CR, Wrogemann K, Blonden LAJ, van Paassen HMB, van Ommen GJB, Kunkel LM. 1989. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. American Journal of Human Genetics 45:498-506.
38. Konieczny P, Swiderski K, Chamberlain JS. 2013. Gene and cell-mediated therapies for muscular dystrophy. Muscle & Nerve 47:649-663. doi: 10.1002/mus.23738.
39. Kunkel LM, Bachrach E, Bennett RR, Guyon J, Steffen L. 2006. Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish. Journal of Human Genetics 51:397-406. doi: 10.1007/ s10038-006-0374-9.
40. Lai D, Lan CC, Leong IUS, Love DR. 2012. Zebrafish dystrophin and utrophin genes: dissecting transcriptional expression during embryonic development. International Journal of Molecular Medicine 29:338-348. doi: 10.3892/ijmm.2011.865.
41. Larsen CA, Howard MT. 2014. Conserved regions of the DMD 3′ UTR regulate translation and mRNA abundance in cultured myotubes. Neuromuscular Disorders 24:693-706. doi: 10.1016/j.nmd.2014.05.006.
42. Le Rumeur E, Winder SJ, Hubert JF. 2010. Dystrophin: more than just the sum of its parts. Biochimica et Biophysica Acta 1804:1713-1722. doi: 10.1016/j.bbapap.2010.05.001.
43. Levine BA, Moir AJ, Patchell VB, Perry SV. 1992. Binding sites involved in the interaction of actin with the N-terminal region of dystrophin. FEBS Letters 298:44-48. doi: 10.1016/0014-5793(92)80019-D.
44. Masuda T, Fujimaki N, Ozawa E, Ishikawa H. 1992. Confocal laser microscopy of dystrophin localization in guinea pig skeletal muscle fibers. The Journal of Cell Biology 119:543-548. doi: 10.1083/jcb.119.3.543.
45. Miranda AF, Bonilla E, Martucci G, Moraes CT, Hays AP, Dimauro S. 1988. Immunocytochemical study of dystrophin in muscle cultures from patients with Duchenne muscular dystrophy and unaffected control patients. The American Journal of Pathology 132:410-416.
46. Miyatake M, Miike T, Zhao JE, Yoshioka K, Uchino M, Usuku G. 1991. Dystrophin: localization and presumed function. Muscle & Nerve 14:113-119. doi: 10.1002/mus.880140205.
47. Mora M, Di Blasi C, Barresi R, Morandi L, Brambati B, Jarre L, Cornelio F. 1996. Developmental expression of dystrophin, dystrophin-associated glycoproteins and other membrane cytoskeletal proteins in human skeletal and heart muscle. Brain Research 91:70-82. doi: 10.1016/0165-3806(95)00169-7.
48. Mueller F, Morisaki T, Mazza D, McNally JG. 2012. Minimizing the impact of photoswitching of fluorescent proteins on FRAP analysis. Biophysical Journal 102:1656-1665. doi: 10.1016/j.bpj.2012.02.029.
49. Müller P, Rogers KW, Jordan BM, Lee JS, Robson D, Ramanathan S, Schier AF. 2012. Differential diffusivity of Nodal and Lefty underlies a reaction-diffusion patterning system. Science 336:721-724. doi: 10.1126/science.1221920.
50. Peri V, Ajdukovic B, Holland P, Tuana BS. 1994. Dystrophin predominantly localizes to the transverse tubule/Z-line regions of single ventricular myocytes and exhibits distinct associations with the membrane. Molecular and Cellular Biochemistry 130:57-65. doi: 10.1007/BF01084268.
51. Pons F, Augier N, Heilig R, Léger J, Mornet D, Léger JJ. 1990. Isolated dystrophin molecules as seen by electron microscopy. Proceedings of the National Academy of Sciences of USA 87:7851-7855. doi: 10.1073/pnas.87.20.7851.
52. Ruf-Zamojski F, Trivedi V, Fraser SE, Trinh LA. 2015. Spatio-temporal differences in dystrophin dynamics at mRNA and protein levels revealed by a novel FlipTrap line. PLOS ONE 10:e0128944. doi: 10.1371/journal.pone.0128944.
53. Rybakova IN, Amann KJ, Ervasti JM. 1996. A new model for the interaction of dystrophin with F-actin. The Journal of Cell Biology 135:661-672. doi: 10.1083/jcb.135.3.661.
54. Rybakova IN, Patel JR, Ervasti JM. 2000. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. The Journal of Cell Biology 150:1209-1214. doi: 10.1083/jcb.150.5.1209.
55. Sadegh Zadeh K, Montas HJ, Shirmohammadi A. 2006. Identification of biomolecule mass transport and binding rate parameters in living cells by inverse modeling. Theoretical Biology & Medical Modelling 3:36. doi: 10.1186/ 1742-4682-3-36.
56. Samitt CE, Bonilla E. 1990. Immunocytochemical study of dystrophin at the myotendinous junction. Muscle & Nerve 13:493-500. doi: 10.1002/mus.880130605.
57. Spence HJ, Chen YJ, Batchelor CL, Higginson JR, Suila H, Carpen O, Winder SJ. 2004. Ezrin-dependent regulation of the actin cytoskeleton by beta-dystroglycan. Human Molecular Genetics 13:1657-1668. doi: 10.1093/hmg/ ddh170.
58. Tennyson CN, Shi Q, Worton RG. 1996. Stability of the human dystrophin transcript in muscle. Nucleic Acids Research 24:3059-3064. doi: 10.1093/nar/24.15.3059.
59. Torelli S, Ferlini A, Obici L, Sewry C, Muntoni F. 1999. Expression, regulation and localisation of dystrophin isoforms in human foetal skeletal and cardiac muscle. Neuromuscular Disorders 9:541-551. doi: 10.1016/S0960-8966(99)00048-6.
60. Trinh LA, Hochgreb T, Graham M, Wu D, Ruf-Zamojski F, Jayasena CS, Saxena A, Hawk R, Gonzalez-Serricchio A, Dixson A, Chow E, Gonzales C, Leung HY, Solomon I, Bronner-Fraser M, Megason SG, Fraser SE. 2011. A versatile gene trap to visualize and interrogate the function of the vertebrate proteome. Genes & Development 25:2306-2320. doi: 10.1101/gad.174037.111.
61. Verhaart IEC, van Vliet-Van den Dool L, Sipkens JA, de Kimpe SJ, Kolfschoten IG, van Deutekom JC, Liefaard L, Ridings JE, Hood SR, Aartsma-Rus A. 2014. The dynamics of compound, transcript, and protein effects after treatment with 2OMePS antisense oligonucleotides in mdx mice. Molecular Therapy 3:e148. doi: 10.1038/mtna. 2014.1.
62. Waugh TA, Horstick E, Hur J, Jackson SW, Davidson AE, Li X, Dowling JJ. 2014. Fluoxetine prevents dystrophic changes in a zebrafish model of duchenne muscular dystrophy. Human Molecular Genetics 23:4651-4662. doi: 10.1093/hmg/ddu185.
63. Weber SC, Spakowitz AJ, Theriot JA. 2012. Nonthermal ATP-dependent fluctuations contribute to the in vivo motion of chromosomal loci. Proceedings of the National Academy of Sciences of USA 109:7338-7343. doi: 10.1073/pnas.1119505109.
64. Weiss M. 2004. Challenges and artifacts in quantitative photobleaching experiments. Traffic 5:662-671. doi: 10.1111/j.1600-0854.2004.00215.x.
65. Wessels A, Ginjaar IB, Moorman AF, van Ommen GJ. 1991. Different localization of dystrophin in developing and adult human skeletal muscle. Muscle & Nerve 14:1-7. doi: 10.1002/mus.880140102.
66. Westerfield M. 1995. The zebrafish book-a guide for the laboratory use of zebrafish (Danio rerio). 3rd edition, University of Oregon Press. Eugene.
67. Wood AJ, Currie PD. 2014. Analysing regenerative potential in zebrafish models of congenital muscular dystrophy. The International Journal of Biochemistry & Cell Biology 56:30-37. doi: 10.1016/j.biocel.2014.10.021.
68. Yonemura S, Wada Y, Watanabe T, Nagafuchi A, Shibata M. 2010. alpha-Catenin as a tension transducer that induces adherens junction development. Nature Cell Biology 12:533-542. doi: 10.1038/ncb2055.
69. Zhao J, Yoshioka K, Miyatake M, Miike T. 1992. Dystrophin and a dystrophin-related protein in intrafusal muscle fibers, and neuromuscular and myotendinous junctions. Acta Neuropathologica 84:141-146. doi: 10.1007/BF00311386.